4[1]Borison RL.The role of cognition in the risk-benefit and safety analysis of antipsychotic medication.Acta Psychiatr Scand,1996,389(suppl):40
5[2]Rossi A,Mancini F,Strata P,et al.Risperidone negative symptoms and cognitive deficit in schizophenia:an open study.Acta Psychiatr Scand,1997,95:40
6[3]Gallhofer B,Bauer U,Lis S,et al.Cognitive dysfunction in schizophrenia:comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.Eur Neuropsy-chopharmacology,1996,6(suppl 2):S13
